CUTISS AG and CSEM have been awarded a grant of more than CHF 800’000 by Innosuisse to develop the first-ever automated machine to bioengineer personalised skin grafts for therapy!
The patient is taken a small skin sample (biopsy), which is sent to the laboratory. This must be treated with the utmost care. denovoFix protects the biopsy from contamination, shreds it and transfers it to the machine via fluid connection for standardized production of the skin graft. A closed, sterile process is guaranteed.